We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

99 hedge funds and large institutions have $91M invested in iShares US Pharmaceuticals ETF in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

50% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 12

15% more capital invested

Capital invested by funds: $78.9M → $91M (+$12.1M)

8.28% more ownership

Funds ownership: 67.77% → 76.05% (+8.3%)

5% more funds holding

Funds holding: 94 → 99 (+5)

Holders
99
Holders Change
+5
Holders Change %
+5.32%
% of All Funds
1.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
33
Reduced
21
Closed
12
Calls
$592K
Puts
–
Net Calls
+$592K
Net Calls Change
-$133K

Top Buyers

1
TRCT
Tower Research Capital (TRC)
New York
+$5.93M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.93M
3
Wells Fargo
Wells Fargo
California
+$1.24M
4
LPL Financial
LPL Financial
California
+$988K
5
Bank of America
Bank of America
North Carolina
+$974K

Top Sellers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$6.49M
2
CFGS
Concourse Financial Group Securities
Alabama
-$3.55M
3
DS
DRW Securities
Illinois
-$568K
4
CS
Candriam SCA
Luxembourg
-$294K
5
FWCM
Ferguson Wellman Capital Management
Oregon
-$240K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$7.93M +$89.4K +1,569 +1%
Brown Advisory
2
Brown Advisory
Maryland
$7.2M -$103K -1,800 -1%
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$7.18M +$1.93M +33,897 +39%
TRCT
4
Tower Research Capital (TRC)
New York
$6.7M +$5.93M +104,082 +1,325%
Bank of America
5
Bank of America
North Carolina
$6.1M +$974K +17,082 +20%
RJA
6
Raymond James & Associates
Florida
$4.44M +$661K +11,601 +19%
LPL Financial
7
LPL Financial
California
$4.31M +$988K +17,331 +32%
Wells Fargo
8
Wells Fargo
California
$3.8M +$1.24M +21,777 +52%
MCM
9
Murphy Capital Management
New Jersey
$3.44M -$67.5K -1,185 -2%
SPIA
10
Steward Partners Investment Advisory
New York
$3.03M +$11.1K +195 +0.4%
Citadel Advisors
11
Citadel Advisors
Florida
$2.9M +$281K +4,929 +11%
Commonwealth Equity Services
12
Commonwealth Equity Services
Massachusetts
$2.71M +$1.2K +21 +0%
UBS Group
13
UBS Group
Switzerland
$2.23M +$182K +3,195 +9%
Envestnet Asset Management
14
Envestnet Asset Management
Illinois
$1.8M +$186K +3,255 +12%
Fisher Asset Management
15
Fisher Asset Management
Washington
$1.67M +$710K +12,453 +81%
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$1.5M -$6.49M -113,826 -82%
Truist Financial
17
Truist Financial
North Carolina
$1.3M +$141K +2,478 +13%
ST
18
Spinnaker Trust
Maine
$1.27M -$94.2K -1,653 -7%
CFA
19
Cahill Financial Advisors
Minnesota
$1.27M +$855 +15 +0.1%
Osaic Holdings
20
Osaic Holdings
Arizona
$1.19M -$32.5K -570 -3%
PP
21
Patten & Patten
Tennessee
$1.1M -$8.55K -150 -0.8%
WIA
22
Wealthstreet Investment Advisors
Texas
$1.06M -$183K -3,210 -15%
Janney Montgomery Scott
23
Janney Montgomery Scott
Pennsylvania
$1.06M -$28.7K -504 -3%
CG
24
Colony Group
Massachusetts
$1.01M +$961K +16,857 New
TYCC
25
Texas Yale Capital Corp
Florida
$863K – – –
1
2 3 4 5

IHE Hedge Fund Activity: Q4 2020 in Review

99 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q4 2020, worth a combined $91M — up 15% from $78.9M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new IHE positions and 12 closed out — a net gain of 6 holders — while 33 added to existing stakes and 21 trimmed.

The largest buyer was Tower Research Capital (TRC), adding an estimated $5.93M. The largest seller was Susquehanna International Group, cutting an estimated $6.49M.

  • 99 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q4 2020, up from 94 in Q3 2020.
  • Funds reported $91M of iShares US Pharmaceuticals ETF stock for Q4 2020, up 15% quarter-over-quarter.
  • 18 funds opened new iShares US Pharmaceuticals ETF positions in Q4 2020 and 12 closed out, a net change of +6 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q4 2020 was Tower Research Capital (TRC), an estimated $5.93M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q4 2020 was Susquehanna International Group, an estimated $6.49M sold.

Based on aggregated 13F filings for Q4 2020.